drugset / Trial / NCT00093678

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

NCT00093678

RandomizedDouble-blindSupportive care

Summary

RATIONALE: Celecoxib may help relieve moderate or severe pain associated with cancer. It may also decrease weight loss and improve muscle strength in cancer patients. PURPOSE: This randomized clinical trial is studying celecoxib to see how well it works in managing pain, weight loss, and weakness in patients with advanced cancer.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified Oral